Drug Development
Focus on innovative drugs for anti infection and inflammatory metabolism, layout lead compound screening, pharmacological evaluation, preclinical research, and promote the pipeline of innovative candidate drugs.
Hong Kong Biopharmaceuticals is laying out innovative drug research and development in areas such as anti infection and metabolic inflammation, covering target research, lead molecule screening, pharmacological and toxicological evaluation, formulation development, and preclinical pipeline promotion.
Scope of Business
- ✓候选新药早期发现与靶点验证
- ✓药物分子优化、制剂工艺开发
- ✓临床前研究方案设计与项目管理
